Acute effects of different glycemic index diets on serum motilin, orexin and neuropeptide Y concentrations in healthy individuals

Neuropeptides

Volumn 46, Issue 3, 2012, Pages 113-118

  Wu, Hui ^a   Xia, Fang zhen ^a   Xu, Hui ^a   Zhai, Hua ling ^a   Zhang, Mei fang ^a   Zhang, Hui xin ^a   Li, Yan xiang ^a   Li, Ying ^a   Gu, Ting ^a   Ma, Li min ^a   Lu, Ying li ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Diet; Glycemic index; Motilin; NPY; Orexin

Indexed keywords

C PEPTIDE; GLUCOSE; MOTILIN; NEUROPEPTIDE Y; OREXIN;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); ENERGY BALANCE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC INDEX; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

ADULT; BLOOD PRESSURE; DIET; EATING; ENERGY METABOLISM; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOENZYME TECHNIQUES; INSULIN-SECRETING CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MOTILIN; NEUROPEPTIDE Y; NEUROPEPTIDES; YOUNG ADULT;

EID: 84862787415     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2012.02.001     Document Type: Article

References (41)

1. Avrameas S. Amplification systems in immunoenzymatic techniques. J. Immunol. Methods 1992, 150:23-32.
2. Baccari B.C. Orexins and gastrointestinal functions. Curr. Protein Pept. Sci. 2010, 11:148-155.
3. Barclay A.W., Petocz P., McMillan-Price J., Flood V.M., Prvan T., Mitchell P., Brand-Miller J.C. Glycemic index, glycemic load, and chronic disease risk - a meta-analysis of observational studies. Am. J. Clin. Nutr. 2008, 87:627-637.
4. Beck B., Stricker-Krongrad A., Nicolas J.P., Burlet C. Chronic and continuous intracerebroventricular infusion of neuropeptide Y in Long-Evans rats mimics the feeding behaviour of obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 1992, 16:295-302.
5. Bulbul M., Tan R., Gemici B., Ozdem S., Ustunel I., Acar N., Izgut-Uysal V.N. Endogenous orexin-A modulates gastric motility by peripheral mechanisms in rats. Peptides 2010, 31:1099-1108.
6. Chen H.Y., Trumbauer M.E., Chen A.S., Weingarth D.T., Adams J.R., Frazier E.G., Shen Z., Marsh D.J., Feighner S.D., Guan X.M., Ye Z., Nargund R.P., Smith R.G., Van der Ploeg L.H., Howard A.D., MacNeil D.J., Qian S. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 2004, 145:2607-2612.
7. Cho Y.R., Kim C.W. Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation. Biochem. Biophys. Res. Commun. 2004, 314:773-780.
8. Choi D.L., Davis J.F., Fitzgerald M.E., Benoit S.C. The role of orexin-A in food motivation, reward-based feeding behavior and food-induced neuronal activation in rats. Neuroscience 2010, 167:11-20.
9. Dieguez C., Vazquez M.J., Romero A., Lopez M., Nogueiras R. Hypothalamic control of lipid metabolism: focus on leptin, ghrelin and melanocortins. Neuroendocrinology 2011, 94:1-11.
10. Dryden S., Pickavance L., Frankish H.M., Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 1995, 690:185-188.
11. Ehrstrom M., Levin F., Kirchgessner A.L., Schmidt P.T., Hilsted L.M., Gryback P., Jacobsson H., Hellstrom P.M., Naslund E. Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. Regul. Pept. 2005, 132:9-16.
12. Feighner S.D., Tan C.P., McKee K.K., Palyha O.C., Hreniuk D.L., Pong S.S., Austin C.P., Figueroa D., MacNeil D., Cascieri M.A., Nargund R., Bakshi R., Abramovitz M., Stocco R., Kargman S., O'Neill G., Van Der Ploeg L.H., Evans J., Patchett A.A., Smith R.G., Howard A.D. Receptor for motilin identified in the human gastrointestinal system. Science 1999, 284:2184-2188.
13. Fu L.Y., Acuna-Goycolea C., van den Pol A.N. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 2004, 24:8741-8751.
14. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 361:512-519.
15. Hagander B., Asp N.G., Ekman R., Nilsson-Ehle P., Schersten B. Dietary fibre enrichment, blood pressure, lipoprotein profile and gut hormones in NIDDM patients. Eur. J. Clin. Nutr. 1989, 43:35-44.
16. Heinonen M.V., Purhonen A.K., Makela K.A., Herzig K.H. Functions of orexins in peripheral tissues. Acta Physiol. (Oxf) 2008, 192:471-485.
17. Howlett J., Ashwell M. Glycemic response and health: summary of a workshop. Am. J. Clin. Nutr. 2008, 87:212S-216S.
18. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol. Motil. 1999, 11:141-161.
19. Ilhan A., Rasul S., Dimitrov A., Handisurya A., Gartner W., Baumgartner-Parzer S., Wagner L., Kautzky-Willer A., Base W. Plasma neuropeptide Y levels differ in distinct diabetic conditions. Neuropeptides 2010, 44:485-489.
20. Itoh Z. Motilin and clinical application. Peptides 1997, 18:593-608.
21. Jenkins D.J., Kendall C.W., McKeown-Eyssen G., Josse R.G., Silverberg J., Booth G.L., Vidgen E., Josse A.R., Nguyen T.H., Corrigan S., Banach M.S., Ares S., Mitchell S., Emam A., Augustin L.S., Parker T.L., Leiter L.A. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008, 300:2742-2753.
22. Jenkins D.J., Wolever T.M., Taylor R.H., Barker H., Fielden H., Baldwin J.M., Bowling A.C., Newman H.C., Jenkins A.L., Goff D.V. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 1981, 34:362-366.
23. Kastin A.J., Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J. Pharmacol. Exp. Ther. 1999, 289:219.
24. Konturek S.J., Konturek J.W., Pawlik T., Brzozowski T. Brain-gut axis and its role in the control of food intake. J. Physiol. Pharmacol. 2004, 55:137-154.
25. Kopp W. The atherogenic potential of dietary carbohydrate. Prev. Med. 2006, 42:336-342.
26. Kopp W. Chronically increased activity of the sympathetic nervous system: our diet-related "evolutionary" inheritance. J. Nutr. Health Aging 2009, 13:27-29.
27. Kos K., Harte A.L., James S., Snead D.R., O'Hare J.P., McTernan P.G., Kumar S. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1335-E1340.
28. Martynska L., Wolinska-Witort E., Chmielowska M., Bik W., Baranowska B. The physiological role of orexins. Neuro Endocrinol. Lett. 2005, 26:289-292.
29. Miller M.A., Sagnella G.A., Markandu N.D., MacGregor G.A. Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation. Clin. Chim. Acta 1990, 192:47-53.
30. Murphy K.G., Dhillo W.S., Bloom S.R. Gut peptides in the regulation of food intake and energy homeostasis. Endocr. Rev. 2006, 27:719-727.
31. Neyrinck A.M., Delzenne N.M. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:722-728.
32. Nguyen A.D., Herzog H., Sainsbury A. Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr. Opin. Endocrinol. Diabetes Obes. 2011, 18:56-60.
33. Nowak K.W., Mackowiak P., Switonska M.M., Fabis M., Malendowicz L.K. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci. 2000, 66:449-454.
34. Ozaki K., Monnai M., Onoma M., Muramatsu H., Yogo K., Watanabe T., Oda Y., Katagiri K., Arakawa H., Itoh Z., Omura S., Takanashi H. Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes. J. Diabetes Complications 2008, 22:339-347.
35. Perello M., Scott M.M., Sakata I., Lee C.E., Chuang J.C., Osborne-Lawrence S., Rovinsky S.A., Elmquist J.K., Zigman J.M. Functional implications of limited leptin receptor and ghrelin receptor co-expression in the brain. J. Comp. Neurol 2011, 10.1002/cne.22690.
36. Poitras P., Peeters T.L. Motilin. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15:54-57.
37. Popkin B.M. Will China's nutrition transition overwhelm its health care system and slow economic growth. Health Aff. 2008, 27:1064.
38. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
39. Wolever T.M., Jenkins D.J. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am. J. Clin. Nutr. 1986, 43:167-172.
40. Wu C.L., Nicholas C., Williams C., Took A., Hardy L. The influence of high-carbohydrate meals with different glycaemic indices on substrate utilisation during subsequent exercise. Br. J. Nutr. 2003, 90:1049-1056.
41. Zukowska Z., Pons J., Lee E.W., Li L. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system. Can. J. Physiol. Pharmacol. 2003, 81:89-94.